eXoZymes (NASDAQ:EXOZ - Get Free Report) announced its quarterly earnings data on Tuesday. The company reported ($0.28) earnings per share (EPS) for the quarter, Zacks reports.
eXoZymes Trading Down 2.9%
Shares of NASDAQ:EXOZ traded down $0.29 during trading on Friday, hitting $9.70. The stock had a trading volume of 486 shares, compared to its average volume of 4,294. eXoZymes has a 12-month low of $8.50 and a 12-month high of $23.99. The company has a quick ratio of 6.52, a current ratio of 6.19 and a debt-to-equity ratio of 0.01. The business's 50-day moving average price is $10.45.
About eXoZymes
(
Get Free Report)
eXoZymes, Inc is a development stage synthetic biochemical company. Its synthetic biology platform would enable the scalable exploration of many molecules and properties found in nature. The company was founded by Tyler Korman and Paul Opgenorth in April 2019 and is headquartered in Monrovia, NV.
See Also
Before you consider eXoZymes, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and eXoZymes wasn't on the list.
While eXoZymes currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Just getting into the stock market? These 10 simple stocks can help beginning investors build long-term wealth without knowing options, technicals, or other advanced strategies.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
MarketBeat All Access